Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity
- Authors:
- Christin Türke
- Susanne Horn
- Carola Petto
- Dirk Labudde
- Günter Lauer
- Gretel Wittenburg
-
Affiliations: Department for Oral and Maxillofacial Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, and German Consortium for Translational Cancer Research (DKTK), Essen, Germany, Department of Bioinformatics, University of Applied Sciences Mittweida, Mittweida, Germany - Published online on: April 24, 2017 https://doi.org/10.3892/ijo.2017.3974
- Pages: 2207-2220
This article is mentioned in:
Abstract
Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar : PubMed/NCBI | |
Sadick M, Schoenberg SO, Hoermann K and Sadick H: Aktuelle Standards und Fortschritte in der onkologischen Bildgebung von Kopf-Hals-Tumoren. Laryngorhinootologie. 91(Suppl 1): S27–S47. 2012. View Article : Google Scholar | |
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kademani D: Oral cancer. Mayo Clin Proc. 82:878–887. 2007. View Article : Google Scholar : PubMed/NCBI | |
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, et al: Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 11:21–28. 2010. View Article : Google Scholar | |
Forastiere A, Koch W, Trotti A and Sidransky D: Head and neck cancer. N Engl J Med. 345:1890–1900. 2001. View Article : Google Scholar | |
Maier H, Dietz A, Gewelke U, Heller WD and Weidauer H: Tobacco and alcohol and the risk of head and neck cancer. Clin Investig. 70:320–327. 1992.PubMed/NCBI | |
Lewin F, Norell SE, Johansson H, Gustavsson P, Wennerberg J, Biörklund A and Rutqvist LE: Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: A population-based case-referent study in Sweden. Cancer. 82:1367–1375. 1998. View Article : Google Scholar : PubMed/NCBI | |
Viswanathan H and Wilson JA: Alcohol - the neglected risk factor in head and neck cancer. Clin Otolaryngol Allied Sci. 29:295–300. 2004. View Article : Google Scholar : PubMed/NCBI | |
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A and Gillison ML: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 100:261–269. 2008. View Article : Google Scholar : PubMed/NCBI | |
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 92:709–720. 2000. View Article : Google Scholar : PubMed/NCBI | |
Trizna Z and Schantz SP: Hereditary and environmental factors associated with risk and progression of head and neck cancer. Otolaryngol Clin North Am. 25:1089–1103. 1992.PubMed/NCBI | |
Hecht F and Hecht BK: Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogenet. 46:9–19. 1990. View Article : Google Scholar : PubMed/NCBI | |
Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature. 351:453–456. 1991. View Article : Google Scholar : PubMed/NCBI | |
Blons H and Laurent-Puig P: TP53 and head and neck neoplasms. Hum Mutat. 21:252–257. 2003. View Article : Google Scholar : PubMed/NCBI | |
Erber R, Conradt C, Homann N, Enders C, Finckh M, Dietz A, Weidauer H and Bosch FX: TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene. 16:1671–1679. 1998. View Article : Google Scholar : PubMed/NCBI | |
Nylander K, Dabelsteen E and Hall PA: The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med. 29:413–425. 2000. View Article : Google Scholar : PubMed/NCBI | |
Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, et al: The mutational landscape of head and neck squamous cell carcinoma. Science. 333:1157–1160. 2011. View Article : Google Scholar : PubMed/NCBI | |
Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et al: Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 333:1154–1157. 2011. View Article : Google Scholar : PubMed/NCBI | |
Skinner HD1, Sandulache VC, Ow TJ, Meyn RE, Yordy JS, Beadle BM, Fitzgerald AL, Giri U, Ang KK and Myers JN: TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. Clin Cancer Res. 18:290–300. 2012. View Article : Google Scholar : | |
Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG, Goberdhan A, Shah JP and Singh B: High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg. 129:106–112. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, Hanenberg H and Auerbach AD: A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 101:1249–1256. 2003. View Article : Google Scholar | |
Rosenberg PS, Socié G, Alter BP and Gluckman E: Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 105:67–73. 2005. View Article : Google Scholar | |
Walden H and Deans AJ: The Fanconi anemia DNA repair pathway: Structural and functional insights into a complex disorder. Annu Rev Biophys. 43:257–278. 2014. View Article : Google Scholar : PubMed/NCBI | |
Chandrasekharappa SC, Lach FP, Kimble DC, Kamat A, Teer JK, Donovan FX, Flynn E, Sen SK, Thongthip S, Sanborn E, et al: NISC Comparative Sequencing Program: Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. Blood. 121:e138–e148. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wreesmann VB, Estilo C, Eisele DW, Singh B and Wang SJ: Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 69:218–225. 2007. View Article : Google Scholar : PubMed/NCBI | |
Pfeiffer J, Maier W, Ridder GJ, Zaoui K and Birkenhäger R: LOH-profiling by SNP-mapping in a case of multifocal head and neck cancer. World J Clin Oncol. 3:24–28. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sparano A, Quesnelle KM, Kumar MS, Wang Y, Sylvester AJ, Feldman M, Sewell DA, Weinstein GS and Brose MS: Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope. 116:735–741. 2006. View Article : Google Scholar : PubMed/NCBI | |
Bockmühl U, Schlüns K, Schmidt S, Matthias S and Petersen I: Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer. 33:29–35. 2002. View Article : Google Scholar | |
Koy S, Hauses M, Appelt H, Friedrich K, Schackert HK and Eckelt U: Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck. Head Neck. 26:338–344. 2004. View Article : Google Scholar : PubMed/NCBI | |
Weber F, Xu Y, Zhang L, Patocs A, Shen L, Platzer P and Eng C: Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. JAMA. 297:187–195. 2007. View Article : Google Scholar : PubMed/NCBI | |
Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM and Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res. 54:1152–1155. 1994.PubMed/NCBI | |
Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ and Helleday T: Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 434:913–917. 2005. View Article : Google Scholar : PubMed/NCBI | |
Duan W, Gao L, Zhao W, Leon M, Sadee W, Webb A, Resnick K, Wu X, Ramaswamy B, Cohn DE, et al: Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: A potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents. Transl Res. 161:156–164. 2013. View Article : Google Scholar | |
de Winter JP, Rooimans MA, van Der Weel L, van Berkel CG, Alon N, Bosnoyan-Collins L, de Groot J, Zhi Y, Waisfisz Q, Pronk JC, et al: The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet. 24:15–16. 2000. View Article : Google Scholar | |
Ahmad SI and Kirk SH: Molecular Mechanisms of Fanconi Anemia. Landes Bioscience/Eurekah.com; 2006 | |
de Winter JP, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F, Scheper RJ, Kruyt FA, Hoatlin ME and Joenje H: The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet. 9:2665–2674. 2000. View Article : Google Scholar : PubMed/NCBI | |
Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC and D'Andrea AD: Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 9:568–574. 2003. View Article : Google Scholar : PubMed/NCBI | |
Olopade OI and Wei M: FANCF methylation contributes to chemoselectivity in ovarian cancer. Cancer Cell. 3:417–420. 2003. View Article : Google Scholar : PubMed/NCBI | |
Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M and Kelsey KT: Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: Implications for treatment and survival. Oncogene. 23:1000–1004. 2004. View Article : Google Scholar | |
Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Mansukhani M, Villella J, Meyer L, Schneider A, et al: Promoter hypermethylation of FANCF: Disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res. 64:2994–2997. 2004. View Article : Google Scholar : PubMed/NCBI | |
Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ, et al: Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors. Mol Cancer. 3:162004. View Article : Google Scholar : PubMed/NCBI | |
de Winter JP, Waisfisz Q, Rooimans MA, van Berkel CG, Bosnoyan-Collins L, Alon N, Carreau M, Bender O, Demuth I, Schindler D, et al: The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet. 20:281–283. 1998. View Article : Google Scholar : PubMed/NCBI | |
Demuth I, Wlodarski M, Tipping AJ, Morgan NV, de Winter JP, Thiel M, Gräsl S, Schindler D, D'Andrea AD, Altay C, et al: Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9. Eur J Hum Genet. 8:861–868. 2000. View Article : Google Scholar : PubMed/NCBI | |
Gallmeier E, Calhoun ES, Rago C, Brody JR, Cunningham SC, Hucl T, Gorospe M, Kohli M, Lengauer C and Kern SE: Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options. Gastroenterology. 130:2145–2154. 2006. View Article : Google Scholar : PubMed/NCBI | |
Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW, Elghalbzouri-Maghrani E, Steltenpool J, Rooimans MA, Pals G, et al: The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet. 37:934–935. 2005. View Article : Google Scholar : PubMed/NCBI | |
Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, Rio P, Batish SD, Kalb R, Velleuer E, Barral S, et al: The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet. 37:931–933. 2005. View Article : Google Scholar : PubMed/NCBI | |
Litman R, Peng M, Jin Z, Zhang F, Zhang J, Powell S, Andreassen PR and Cantor SB: BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell. 8:255–265. 2005. View Article : Google Scholar : PubMed/NCBI | |
Xie J, Peng M, Guillemette S, Quan S, Maniatis S, Wu Y, Venkatesh A, Shaffer SA, Brosh RM Jr and Cantor SB: FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage response. PLoS Genet. 8:e10027862012. View Article : Google Scholar : PubMed/NCBI | |
Cantor SB and Guillemette S: Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Future Oncol. 7:253–261. 2011. View Article : Google Scholar : PubMed/NCBI | |
Sobin LH and Fleming ID: TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI | |
Idbaih A, Carvalho Silva R, Crinière E, Marie Y, Carpentier C, Boisselier B, Taillibert S, Rousseau A, Mokhtari K, Ducray F, et al: Genomic changes in progression of low-grade gliomas. J Neurooncol. 90:133–140. 2008. View Article : Google Scholar : PubMed/NCBI | |
van Zeeburg HJ, Snijders PJ, Pals G, Hermsen MA, Rooimans MA, Bagby G, Soulier J, Gluckman E, Wennerberg J, Leemans CR, et al: Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. Cancer Res. 65:1271–1276. 2005. View Article : Google Scholar : PubMed/NCBI | |
Nagao T1, Sugano I, Ishida Y, Tajima Y, Munakata S, Asoh A, Yamazaki K, Muto H, Konno A, Kondo Y, et al: Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases. Mod Pathol. 13:554–561. 2000. View Article : Google Scholar : PubMed/NCBI | |
Tarmin L, Yin J, Zhou X, Suzuki H, Jiang HY, Rhyu MG, Abraham JM, Krasna MJ, Cottrell J and Meltzer SJ: Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus. Cancer Res. 54:6094–6096. 1994.PubMed/NCBI | |
Chen CH, Chang CJ, Yang WS, Chen CL and Fann CSJ: A genome-wide scan using tree-based association analysis for candidate loci related to fasting plasma glucose levels. BMC Genet. 4(Suppl 1): S652003. View Article : Google Scholar | |
Powlesland RM, Charles AK, Malik KTA, Reynolds PA, Pires S, Boavida M and Brown KW: Loss of heterozygosity at 7p in Wilms' tumour development. Br J Cancer. 82:323–329. 2000. View Article : Google Scholar : PubMed/NCBI | |
Orsetti B, Courjal F, Cuny M, Rodriguez C and Theillet C: 17q21–q25 aberrations in breast cancer: Combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification. Oncogene. 18:6262–6270. 1999. View Article : Google Scholar : PubMed/NCBI | |
Indraccolo S, Tisato V, Agata S, Moserle L, Ferrari S, Callegaro M, Persano L, Palma MD, Scaini MC, Esposito G, et al: Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 −/− epithelial ovarian cancers. Eur J Cancer. 42:1475–1483. 2006. View Article : Google Scholar : PubMed/NCBI | |
Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA and de la Chapelle A: Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res. 56:3331–3337. 1996.PubMed/NCBI | |
Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR and Quirke P: Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer. 67:1262–1267. 1993. View Article : Google Scholar : PubMed/NCBI | |
Hahn M, Wieland I, Koufaki ON, Görgens H, Sobottka SB, Schackert G and Schackert HK: Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases. Clin Cancer Res. 5:2431–2437. 1999.PubMed/NCBI | |
Ihaka R and Gentleman R: R: A language for data analysis and graphics. J Comput Graph Stat. 5:299–314. 1996. | |
Bland JM and Altman DG: Multiple significance tests: The Bonferroni method. BMJ. 310:1701995. View Article : Google Scholar : PubMed/NCBI | |
Cheng PF, Dummer R and Levesque MP: Data mining The Cancer Genome Atlas in the era of precision cancer medicine. Swiss Med Wkly. 145:w141832015.PubMed/NCBI | |
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI | |
Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, et al: The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38(Web Server): W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI | |
Kuriakose MA, Chen WT, He ZM, Sikora AG, Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, et al: Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci. 61:1372–1383. 2004. View Article : Google Scholar : PubMed/NCBI | |
Hu N, Clifford RJ, Yang HH, Wang C, Goldstein AM, Ding T, Taylor PR and Lee MP: Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics. 11:5762010. View Article : Google Scholar : PubMed/NCBI | |
Zhu B, Yan K, Li L, Lin M, Zhang S, He Q, Zheng D, Yang H and Shao G: K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks. Oncogene. 34:2867–2878. 2015. View Article : Google Scholar | |
Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al: COSMIC: Mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39(Database): D945–D950. 2011. View Article : Google Scholar : | |
Deans AJ and West SC: DNA interstrand crosslink repair and cancer. Nat Rev Cancer. 11:467–480. 2011. View Article : Google Scholar : PubMed/NCBI | |
Ridet A, Guillouf C, Duchaud E, Cundari E, Fiore M, Moustacchi E and Rosselli F: Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res. 57:1722–1730. 1997.PubMed/NCBI | |
Beder LB, Gunduz M, Ouchida M, Fukushima K, Gunduz E, Ito S, Sakai A, Nagai N, Nishizaki K and Shimizu K: Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest. 83:99–105. 2003. View Article : Google Scholar : PubMed/NCBI | |
McHugh PJ, Spanswick VJ and Hartley JA: Repair of DNA inter-strand crosslinks: Molecular mechanisms and clinical relevance. Lancet Oncol. 2:483–490. 2001. View Article : Google Scholar | |
Bridge WL, Vandenberg CJ, Franklin RJ and Hiom K: The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat Genet. 37:953–957. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hoffmann M, Görögh T, Gottschlich S, Lohrey C, Rittgen W, Ambrosch P, Schwarz E and Kahn T: Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett. 218:199–206. 2005. View Article : Google Scholar : PubMed/NCBI | |
Sticht C, Hofele C, Flechtenmacher C, Bosch FX, Freier K, Lichter P and Joos S: Amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC). Br J Cancer. 92:770–774. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hashemi R and Commenges D: Correction of the p-value after multiple tests in a Cox proportional hazard model. Lifetime Data Anal. 8:335–348. 2002. View Article : Google Scholar : PubMed/NCBI | |
Bryne M, Koppang HS, Lilleng R, Stene T, Bang G and Dabelsteen E: New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med. 18:432–437. 1989. View Article : Google Scholar : PubMed/NCBI | |
Kristensen GB, Abeler VM, Risberg B, Trop C and Bryne M: Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol. 74:245–251. 1999. View Article : Google Scholar : PubMed/NCBI | |
Bryne M, Koppang HS, Lilleng R and Kjaerheim A: Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 166:375–381. 1992. View Article : Google Scholar : PubMed/NCBI | |
Lim SL, Smith P, Syed N, Coens C, Wong H, van der Burg M, Szlosarek P, Crook T and Green JA: Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer. Br J Cancer. 98:1452–1456. 2008. View Article : Google Scholar : PubMed/NCBI | |
Begg AC: Predicting recurrence after radiotherapy in head and neck cancer. Semin Radiat Oncol. 22:108–118. 2012. View Article : Google Scholar : PubMed/NCBI | |
Curtin NJ and Szabo C: Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond. Mol Aspects Med. 34:1217–1256. 2013. View Article : Google Scholar : PubMed/NCBI | |
McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, Giavara S, O'Connor MJ, Tutt AN, Zdzienicka MZ, et al: Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res. 66:8109–8115. 2006. View Article : Google Scholar : PubMed/NCBI | |
Nowsheen S, Bonner JA and Yang ES: The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy. Radiother Oncol. 99:331–338. 2011. View Article : Google Scholar : PubMed/NCBI | |
Khan K, Araki K, Wang D, Li G, Li X, Zhang J, Xu W, Hoover RK, Lauter S, O'Malley B Jr, et al: Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427. Head Neck. 32:381–391. 2010. | |
Li Y, Zhao L, Sun H, Yu J, Li N, Liang J, Wang Y, He M, Bai X, Yu Z, et al: Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells. PLoS One. 7:e442542012. View Article : Google Scholar : PubMed/NCBI | |
Yu J, Zhao L, Li Y, Li N, He M, Bai X, Yu Z, Zheng Z, Mi X, Wang E, et al: Silencing of fanconi anemia complementation group f exhibits potent chemosensitization of mitomycin C activity in breast cancer cells. J Breast Cancer. 16:291–299. 2013. View Article : Google Scholar : PubMed/NCBI |